デフォルト表紙
市場調査レポート
商品コード
1378823

顔用注射剤の市場レポート:製品タイプ、用途タイプ、用途、エンドユーザー、地域別、2023-2028年

Facial Injectables Market Report by Product Type, Application Type, Application, End User, and Region 2023-2028

出版日: | 発行: IMARC | ページ情報: 英文 140 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.52円
顔用注射剤の市場レポート:製品タイプ、用途タイプ、用途、エンドユーザー、地域別、2023-2028年
出版日: 2023年11月02日
発行: IMARC
ページ情報: 英文 140 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

概要

顔用注射剤の世界市場規模は2022年に77億米ドルに達しました。今後、IMARC Groupは、市場は2028年までに133億米ドルに達し、2022年から2028年の間に9.5%の成長率(CAGR)を示すと予測しています。

顔用注射剤は、皮膚の外観を向上させるために顔の特定部位に投与されます。これらの注入剤は一般的に、コラーゲン、ヒアルロン酸、カルシウムヒドロキシルアパタイトを使用して作られ、皮膚の弾力性を回復させるのに役立ちます。しわの減少、唇の増大、浅い輪郭の強調、窪んだ傷跡の引き上げなどに使用されます。現在、顔用注射剤は、安全で費用効果が高く、ダウンタイムが最小限であることから、世界中で人気を集めています。

年齢とともにコラーゲンの生成や皮下脂肪の形成が低下すると、皮膚はしわやたるみの影響を受けやすくなります。このことは、高齢者人口の増加や、若々しく健康的な肌を保ちたいという願望と相まって、市場の成長を後押しする重要な要因の一つとなっています。これとは別に、低侵襲手術に対する需要の高まりが、医療・美容ツーリズムの動向と相まって、市場成長に寄与しています。さらに、過度の日焼けが皮膚の組織破壊につながるため、外向的な人々の間で顔用注射剤の需要が高まっています。さらに、可処分所得の増加、ソーシャルメディアの影響力の高まり、オーガニックや生分解性素材を試したがる専門施術者やユーザーの増加は、市場にプラスの影響を与える他の要因の一部です。これに加えて、主要企業はまた、ユーザーにパーソナライズされた経験を提供するために、カスタマイズされた顔用注射剤を提供しており、このことは、今後数年間、市場に前向きな見通しを生み出すと予想されます。

本レポートで扱う主な質問

  • 世界の顔用注射剤の市場成長は?
  • 顔用注射剤の世界市場促進要因は何か?
  • 顔用注射剤の世界市場における主要な業界動向は?
  • COVID-19が顔用注射剤の世界市場に与える影響は?
  • 顔用注射剤の世界市場における製品タイプ別区分は?
  • 顔用注射剤の世界市場内訳:用途タイプ別とは?
  • 顔用注射剤の世界市場エンドユーザー別区分は?
  • 顔用注射剤の世界市場における主要地域は?
  • 顔用注射剤の世界市場における主要企業/プレーヤーは?

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 顔用注射剤の世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳:製品タイプ別

  • コラーゲン
    • 市場動向
    • 市場予測
  • ヒアルロン酸(HA)
    • 市場動向
    • 市場予測
  • A型ボツリヌス毒素
    • 市場動向
    • 市場予測
  • カルシウムハイドロキシアパタイト(CaHA)
    • 市場動向
    • 市場予測
  • ポリメチルメタクリレートビーズ(PMMAマイクロスフェア)
    • 市場動向
    • 市場予測
  • ポリ乳酸(PLLA)
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第7章 市場内訳:用途タイプ別

  • エステティック
    • 市場動向
    • 市場予測
  • 治療薬
    • 市場動向
    • 市場予測

第8章 市場内訳:用途別

  • フェイスライン矯正
    • 市場動向
    • 市場予測
  • リップ形成
    • 市場動向
    • 市場予測
  • フェイスリフト
    • 市場動向
    • 市場予測
  • ニキビ跡治療
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳:エンドユーザー別

  • 病院
    • 市場動向
    • 市場予測
  • 皮膚科クリニック
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第10章 市場内訳:地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳:国別
    • 市場予測

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Allergan Plc
    • Anika Therapeutics Inc.
    • Bloomage BioTechnology
    • Johnson & Johnson
    • Galderma Pharma S.A.
    • Integra LifeSciences
    • Ipsen(Mayroy SA)
    • Medytox Inc.
    • Merz Holding GmbH & Co. KG
    • Prollenium Medical Technologies Inc.
    • Sanofi
    • SciVision Biotech Inc.
    • Sinclair Pharma(Huadong Medicine Co. Ltd.)
    • Suneva Medical Inc.
    • Bausch Health Companies Inc.
図表

List of Figures

  • Figure 1: Global: Facial Injectables Market: Major Drivers and Challenges
  • Figure 2: Global: Facial Injectables Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Facial Injectables Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Facial Injectables Market: Breakup by Product Type (in %), 2022
  • Figure 5: Global: Facial Injectables Market: Breakup by Application Type (in %), 2022
  • Figure 6: Global: Facial Injectables Market: Breakup by Application (in %), 2022
  • Figure 7: Global: Facial Injectables Market: Breakup by End User (in %), 2022
  • Figure 8: Global: Facial Injectables Market: Breakup by Region (in %), 2022
  • Figure 9: Global: Facial Injectables (Collagen) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Facial Injectables (Collagen) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Facial Injectables (Hyaluronic Acid) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Facial Injectables (Hyaluronic Acid) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Facial Injectables (Botulinum Toxin Type A) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Facial Injectables (Botulinum Toxin Type A) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Facial Injectables (Calcium Hydroxylapatite) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Facial Injectables (Calcium Hydroxylapatite) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Facial Injectables (Polymethylmethacrylate Beads) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Facial Injectables (Polymethylmethacrylate Beads) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Facial Injectables (Poly-L-Lactic Acid) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Facial Injectables (Poly-L-Lactic Acid) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Facial Injectables (Other Product Types) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Facial Injectables (Other Product Types) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Facial Injectables (Aesthetics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Facial Injectables (Aesthetics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Facial Injectables (Therapeutics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Facial Injectables (Therapeutics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Facial Injectables (Facial Line Correction) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Facial Injectables (Facial Line Correction) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Facial Injectables (Lip Augmentation) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Facial Injectables (Lip Augmentation) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Facial Injectables (Face Lift) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Facial Injectables (Face Lift) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Global: Facial Injectables (Acne Scar Treatment) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Global: Facial Injectables (Acne Scar Treatment) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Global: Facial Injectables (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Global: Facial Injectables (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Global: Facial Injectables (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Global: Facial Injectables (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Global: Facial Injectables (Dermatology Clinics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Global: Facial Injectables (Dermatology Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Global: Facial Injectables (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Global: Facial Injectables (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: North America: Facial Injectables Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: North America: Facial Injectables Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: United States: Facial Injectables Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: United States: Facial Injectables Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: Canada: Facial Injectables Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: Canada: Facial Injectables Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Asia-Pacific: Facial Injectables Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Asia-Pacific: Facial Injectables Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: China: Facial Injectables Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: China: Facial Injectables Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Japan: Facial Injectables Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: Japan: Facial Injectables Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: India: Facial Injectables Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: India: Facial Injectables Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: South Korea: Facial Injectables Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: South Korea: Facial Injectables Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Australia: Facial Injectables Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Australia: Facial Injectables Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Indonesia: Facial Injectables Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Indonesia: Facial Injectables Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Others: Facial Injectables Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Others: Facial Injectables Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Europe: Facial Injectables Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Europe: Facial Injectables Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Germany: Facial Injectables Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Germany: Facial Injectables Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: France: Facial Injectables Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: France: Facial Injectables Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: United Kingdom: Facial Injectables Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: United Kingdom: Facial Injectables Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Italy: Facial Injectables Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Italy: Facial Injectables Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Spain: Facial Injectables Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Spain: Facial Injectables Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Russia: Facial Injectables Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Russia: Facial Injectables Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Others: Facial Injectables Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: Others: Facial Injectables Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Latin America: Facial Injectables Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 82: Latin America: Facial Injectables Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 83: Brazil: Facial Injectables Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 84: Brazil: Facial Injectables Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 85: Mexico: Facial Injectables Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 86: Mexico: Facial Injectables Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 87: Others: Facial Injectables Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 88: Others: Facial Injectables Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 89: Middle East and Africa: Facial Injectables Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 90: Middle East and Africa: Facial Injectables Market: Breakup by Country (in %), 2022
  • Figure 91: Middle East and Africa: Facial Injectables Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 92: Global: Facial Injectables Industry: SWOT Analysis
  • Figure 93: Global: Facial Injectables Industry: Value Chain Analysis
  • Figure 94: Global: Facial Injectables Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Facial Injectables Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Facial Injectables Market Forecast: Breakup by Product Type (in Million US$), 2023-2028
  • Table 3: Global: Facial Injectables Market Forecast: Breakup by Application Type (in Million US$), 2023-2028
  • Table 4: Global: Facial Injectables Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 5: Global: Facial Injectables Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 6: Global: Facial Injectables Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Facial Injectables Market Structure
  • Table 8: Global: Facial Injectables Market: Key Players
目次
Product Code: SR112023A2814

Abstract

The global facial injectables market size reached US$ 7.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 13.3 Billion by 2028, exhibiting a growth rate (CAGR) of 9.5% during 2022-2028.

Facial injectables are administered on specific areas of the face to enhance the physical appearance of the skin. These injectables are generally made using collagen, hyaluronic acid and calcium hydroxylapatite that help restore the elasticity of the skin. They are used to reduce wrinkles, augment lips, enhance shallow contours and raise depressed scars. Currently, facial injectables are gaining traction worldwide as they are safe, cost-effective and require minimal downtime.

As collagen production and formation of fat under the skin decline with age, the skin becomes more susceptible to wrinkles and sagging. This, in confluence with the growing geriatric population and the desire to retain a young and healthy skin, represents one of the key factors bolstering the market growth. Apart from this, the escalating demand for minimally invasive surgeries, coupled with the rising trend of medical and cosmetic tourism, is contributing to the market growth. Moreover, as excessive sun exposure leads to tissue breakdown of the skin, the demand for facial injectables is escalating among outgoing individuals. Furthermore, inflating disposable incomes, the rising influence of social media, and the growing number of professional practitioners and users willing to try organic and biodegradable materials are some of the other factors influencing the market positively. Besides this, the key players are also offering customized facial injectables to provide a personalized experience to users, which, in turn, is anticipated to create a positive outlook for the market in the coming years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global facial injectables market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product type, application type, application and end user.

Breakup by Product Type:

Collagen

Hyaluronic Acid (HA)

Botulinum Toxin Type A

Calcium Hydroxylapatite (CaHA)

Polymethylmethacrylate Beads (PMMA Microspheres)

Poly-L-Lactic Acid (PLLA)

Others

Breakup by Application Type:

Aesthetics

Therapeutics

Breakup by Application:

Facial Line Correction

Lip Augmentation

Face Lift

Acne Scar Treatment

Others

Breakup by End User:

Hospitals

Dermatology Clinics

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Allergan Plc, Anika Therapeutics Inc., Bloomage BioTechnology, Johnson & Johnson, Galderma Pharma S.A., Integra LifeSciences, Ipsen (Mayroy SA), Medytox Inc., Merz Holding GmbH & Co. KG, Prollenium Medical Technologies Inc., Sanofi, SciVision Biotech Inc., Sinclair Pharma (Huadong Medicine Co. Ltd.), Suneva Medical Inc. and Bausch Health Companies Inc.

Key Questions Answered in This Report

  • 1. What is the global facial injectables market growth?
  • 2. What are the global facial injectables market drivers?
  • 3. What are the key industry trends in the global facial injectables market?
  • 4. What is the impact of COVID-19 on the global facial injectables market?
  • 5. What is the global facial injectables market breakup by product type?
  • 6. What is the global facial injectables market breakup by application type?
  • 7. What is the global voltage regulators market breakup by end user?
  • 8. What are the major regions in the global facial injectables market?
  • 9. Who are the key companies/players in the global facial injectables market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Facial Injectables Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Collagen
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Hyaluronic Acid (HA)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Botulinum Toxin Type A
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Calcium Hydroxylapatite (CaHA)
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Polymethylmethacrylate Beads (PMMA Microspheres)
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Poly-L-Lactic Acid (PLLA)
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Others
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast

7 Market Breakup by Application Type

  • 7.1 Aesthetics
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Therapeutics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Facial Line Correction
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Lip Augmentation
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Face Lift
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Acne Scar Treatment
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Dermatology Clinics
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Allergan Plc
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Anika Therapeutics Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 SWOT Analysis
    • 15.3.3 Bloomage BioTechnology
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Johnson & Johnson
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Galderma Pharma S.A.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 SWOT Analysis
    • 15.3.6 Integra LifeSciences
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Ipsen (Mayroy SA)
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Medytox Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
    • 15.3.9 Merz Holding GmbH & Co. KG
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
    • 15.3.10 Prollenium Medical Technologies Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
    • 15.3.11 Sanofi
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 SciVision Biotech Inc.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
    • 15.3.13 Sinclair Pharma (Huadong Medicine Co. Ltd.)
      • 15.3.13.1 Company Overview
      • 15.3.13.2 Product Portfolio
    • 15.3.14 Suneva Medical Inc.
      • 15.3.14.1 Company Overview
      • 15.3.14.2 Product Portfolio
    • 15.3.15 Bausch Health Companies Inc.
      • 15.3.15.1 Company Overview
      • 15.3.15.2 Product Portfolio
      • 15.3.15.3 Financials
      • 15.3.15.4 SWOT Analysis